Crystal structure of the A3 domain of human von Willebrand factor: Implications for collagen binding

Structure

Volumn 5, Issue 9, 1997, Pages 1147-1156

  Huizinga, Eric G ^a   Van Der Plas, R Martijn ^a   Kroon, Jan ^b   Sixma, Jan J ^a   Gros, Piet ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Collagen binding; Haemostasis; Selenomethionine; Von Willebrand factor; X ray

Indexed keywords

COLLAGEN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BLOOD CLOTTING; CHEMICAL STRUCTURE; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; SURFACE PROPERTY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BINDING SITES; BLOOD COAGULATION; CLONING, MOLECULAR; COLLAGEN; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SURFACE PROPERTIES; VON WILLEBRAND FACTOR;

EID: 0031571750     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0969-2126(97)00266-9     Document Type: Article

References (53)

1. Sixma, J.J. & Wester, J. (1977). The haemostatic plug. Semin. Hematol. 14, 265-299.
2. Ruggeri, Z.M. & Ware, J. (1993). von Willebrand factor. FASEB J. 7, 308-316.
3. Rand, J.H., Wu, X.-X., Potter, B.J., Uson, R.R. & Gordon, R.E. (1993). Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium. Am. J. Pathol. 142, 843-850.
4. Martin, S.E., Marder, V.J., Francis, C.W. & Barlow, G.H. (1981). Structural studies on the functional heterogeneity of von Willebrand protein polymers. Blood 57, 313-323.
5. Slayter, H., Loscalzo, J., Bockenstedt, P. & Handin, R.I. (1985). Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. J. Biol. Chem. 260, 8559-8563.
6. Siedlecki, C.A., Lestini, B.J., Kottke-Marchant, K., Eppell, S.J., Wilson, D.L. & Marchant, R.E. (1996). Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 88, 2939-2950.
7. Titani, K., et al., & Fujikawa, K. (1986). Amino acid sequence of human von Willebrand factor. Biochemistry 25, 3171-3184.
8. Shelton-Inloes, B.B., Titani, K. & Sadler, J.E. (1986). cDNA sequence for human von Willebrand factor reveals five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 25, 3164-3171.
9. Piétu, G., Ribba, A.S., Meulien, P. & Meyer, D. (1989). Localization within the 106 N-terminal amino acids of von Willebrand Factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to Factor VIII. Biochem. Biophys. Res. Commun. 163, 618-626.
10. Beacham, D.A., Wise, R.J., Turci, S.M. & Handin, R.I. (1992). Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. J. Biol. Chem. 267, 3409-3415.
11. Lankhof, H., et al., & Zerwes H.G. (1995). Role of the glycoprotein Ib-binding A1 repeat and the RGD sequence in platelet adhesion to human recombinant von Willebrand factor. Blood 86, 1035-1042.
12. Mohri, H., et al., & Zimmerman, T.S. (1988). Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J. Biol. Chem. 263, 17901-17904.
13. Mohri, H., Yoshioka, A., Zimmerman, T.S. & Ruggeri, Z.M. (1989). Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. J. Biol. Chem. 264, 17361-17367.
14. Sixma, J.J., Schiphorst, M.E., Verweij, C.L. & Pannekoek, H. (1991). Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur. J. Biochem. 196, 369-375.
15. Sobel, M., Soler, D.F., Kermode, J.C. & Harris, R.B. (1992). Localization and characterization of a heparin-binding domain peptide of human von Willebrand factor. J. Biol. Chem. 267, 8857-8862.
16. Christophe, O., Obert, B., Meyer, D. & Girma, J.-P. (1991). The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood 78, 2310-2317.
17. Pareti, F.I., Niiya, K., McPherson, J.M. & Ruggeri, Z.M. (1987). Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J. Biol. Chem. 262, 13835-13841.
18. Pareti, F.I., Fujimura, Y., Dent, J.A., Holland, L.Z., Zimmerman, T.S. & Ruggeri, Z.M. (1986). Isolation and characterization of a collagen-binding domain in human von Willebrand factor. J. Biol. Chem. 261, 15310-15315.
19. Lankhof, H., et al., & Sixma, J.J. (1996). A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb. Haemost. 75, 950-958.
20. Lankhof, H., et al., & Vink, T. (1997). von Willebrand factor without the A2 domain is resistant to proteolysis. Thromb. Haemost. 77, 1008-1013.
21. Furlan, M., Robles, R., Lämmle, B. & Lamie, B. (1996). Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87, 4223-4234.
22. Cruz, M.A., Yuan, H., Lee, J.R., Wise, R.J. & Handin, R.I. (1995). Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF A domain polypeptides. J. Biol. Chem. 270, 10822-10827.
23. Kessler, C.M., Floyd, C.M., Rick, M.E., Krizek, D.M., Lee, S.L. & Gralnick, H.R. (1984). Collagen-factor VIII-von Willebrand factor protein interaction. Blood 63, 1291-1298.
24. Colombatti, A. & Bonaldo, P. (1991). The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77, 2305-2315.
25. Lee, J.O., Rieu, P., Arnaout, M.A. & Liddington, R. (1995). Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell 80, 631-638.
26. Lβ2) integrin. Proc. Natl. Acad. Sci. USA 92, 10277-10281.
27. Michishita, M., Videm, V. & Arnaout, M.A. (1993). A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 72, 857-867.
28. Pietu, G., Fressinaud, E., Girma, J.P., Nieuwenhuis, H.K., Rothschild, C. & Meyer, D. (1987). Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J. Lab. Clin. Med. 109, 637-646.
29. Bockenstedt, P., McDonagh, J. & Handin, R.I. (1986). Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen. J. Clin. Invest. 78, 551-556.
30. Lee, J.-O., Bankston, L.A., Arnaout, M.A. & Liddington, R.C. (1995). Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure 3, 1333-1340.
31. Qu, A. & Leahy, D.J. (1996). The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure 4, 931-942.
32. + binding sites. J. Mol. Biol. 256, 228-234.
33. Branden, C. & Tooze, J. (1991). Alpha/beta structures. In Introduction to Protein Structure. pp 43-57, Garland Publishing Inc., New York.
34. Nicholls, A. (1993). GRASP: Graphical Representation and Analysis of Surface Properties. Colombia University, New York.
35. Kamata, T., Wright, R. & Takada, Y. (1995). Critical threonine and aspartic acid residues within the I domains of β2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J. Biol. Chem. 270, 12531-12535.
36. 2 that differentially affect a divalent cation-dependent conformation. J. Biol. Chem. 270, 25866-25871.
37. Champe, M., McIntyre, B.W. & Berman, P.W. (1995). Monoclonal antibodies that block the activity of leukocyte function-associated antigen 1 recognize three discrete epitopes in the inserted domain of CD11a. J. Biol. Chem. 270, 1388-1394.
38. Huang, C. & Springer, T.A. (1995). A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J. Biol. Chem. 270, 19008-19016.
39. van Genderen, P.J.J., et al., & van Vliet, H.H. (1994). Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 84, 3378-3384.
40. Fitzsimmons, C.M., Cockburn, C.G., Hornsey, V., Prowse, C.V. & Barnes, M.J. (1988). The interaction of von Willebrand factor (vWF) with collagen: investigation of vWF-binding sites in the collagen molecule. Thromb. Haemostas. 59, 186-192.
41. Pickford, A.R., Potts, J.R., Bright, J.R., Phan, I. & Campbell, I.D. (1997). Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. Structure 5, 359-370.
42. Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S. & Tschesche, H. (1994). The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13, 1263-1269.
43. Gomis-Ruth, F.X., et al., & Bode, W. (1996). The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain. J. Mol. Biol. 264, 556-566.
44. Morton, L.F., Griffin, B., Pepper, D.S. & Barnes, M.J. (1983). The interaction between collagens and factor VIII/von Willebrand factor: investigation of the structural requirements for interaction. Thromb. Res. 32, 545-556.
45. Scott, D.M., Griffin, B., Pepper, D.S. & Barnes, M.J. (1981). The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form. Thromb. Res. 24, 467-472.
46. Studier, F.W., Rosenberg, A.H., Junn, J.J. & Dubendorff, J.W. (1990). Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60-89.
47. Studier, F.W. & Moffatt, B.A. (1986). Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189, 113-130.
48. Budisa, N., Steipe, B., Demange, P., Eckerskorn, C., Kellermann, J. & Huber, R. (1995). High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur. J. Biochem. 230, 788-796.
49. Otwinowski, Z. & Minor, W. (1996). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
50. Collaborative Computational Project No.4. (1994). The CCP4 Suite: programs for protein crystallography. Acta Cryst. D 50, 760-763.
51. Jones, T.A., Zou, J.Y., Cowan, S.J. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron-density maps and the location of errors in these models. Acta Cryst. A 47, 110-119.
52. Brünger, A.T. (1992). X-PLOR Version 3.1: A system for X-ray Crystallography and NMR. Yale University Press, New Haven, CT, USA.
53. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.